Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 5:19 PM View:  | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Sep-24 | Option Exercise | 900 | $7.10 | $6,390.00 | 4% 25.01K to 25.91K | |
| 12-Sep-24 5:19 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Sep-24 | Planned Option Sale | 900 | $21.23 | $19,103.70 | (3%) 25.91K to 25.01K | |
| 12-Jun-24 9:40 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Jun-24 | Planned Option Sale | 900 | $24.16 | $21,739.50 | (3%) 25.91K to 25.01K | |
| 12-Jun-24 9:40 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Jun-24 | Option Exercise | 900 | $7.10 | $6,390.00 | 4% 25.01K to 25.91K | |
| 10-Jun-24 6:31 PM View: | Tucker Edwin Jonathan Chief Medical Officer | Jasper Therapeutics, Inc. (JSPR) | 07-Jun-24 | Grant | 400 | $4.17 | $1,669.40 | 100% 0 to 0.4K | |
| 12-Mar-24 9:33 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Mar-24 | Option Exercise | 900 | $7.10 | $6,390.00 | 4% 25.01K to 25.91K | |
| 12-Mar-24 9:33 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Mar-24 | Planned Option Sale | 900 | $26.44 | $23,792.20 | (3%) 25.91K to 25.01K | |
| 09-Feb-24 8:40 PM View: | Velan Capital Investment Ma... 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 08-Feb-24 | Purchase | 350,000 | $12.95 | $4,532,500.00 | 32% 1.08M to 1.43M | |
| 12-Feb-24 6:23 PM View: | Carlyle Group L.P. | Jasper Therapeutics, Inc. (JSPR) | 08-Feb-24 | Purchase | 190,000 | $12.95 | $2,460,500.00 | 22% 876.19K to 1.07M | |
| 30-Nov-23 4:05 PM View: | Wiggans Thomas G Director | Jasper Therapeutics, Inc. (JSPR) | 28-Nov-23 | Purchase | 10,000 | $0.65 | $6,486.00 | 25% 40.0K to 50.0K | |
| 22-Nov-23 4:06 PM View: | Wiggans Thomas G Director | Jasper Therapeutics, Inc. (JSPR) | 21-Nov-23 | Purchase | 10,000 | $0.64 | $6,383.00 | 33% 30.0K to 40.0K | |
| 20-Nov-23 10:00 PM View: | Wiggans Thomas G Director | Jasper Therapeutics, Inc. (JSPR) | 20-Nov-23 | Purchase | 10,000 | $0.63 | $6,309.00 | 50% 20.0K to 30.0K | |
| 20-Nov-23 10:00 PM View: | Wiggans Thomas G Director | Jasper Therapeutics, Inc. (JSPR) | 17-Nov-23 | Purchase | 10,000 | $0.60 | $5,966.00 | 100% 10.0K to 20.0K | |
| 20-Nov-23 10:00 PM View: | Wiggans Thomas G Director | Jasper Therapeutics, Inc. (JSPR) | 16-Nov-23 | Purchase | 10,000 | $0.60 | $5,965.00 | 100% 0 to 10.0K | |
| 13-Oct-23 6:56 PM View: | Lis William Director | Jasper Therapeutics, Inc. (JSPR) | 13-Oct-23 | Sale (Planned) | 7,965 | $0.85 | $6,776.62 | (13%) 61.49K to 53.52K | |
| 13-Oct-23 6:57 PM View: | Martell Ron President, CEO & Director Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-23 | Payment of Exercise | 87,531 | $0.85 | $74,401.40 | (21%) 418.72K to 331.19K | |
| 13-Oct-23 6:58 PM View: | Mahal Jeetinder Singh Chief Operating Officer | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-23 | Payment of Exercise | 37,126 | $0.85 | $31,557.10 | (13%) 287.22K to 250.1K | |
| 13-Jun-23 10:00 PM View: | Mahal Jeetinder Singh See Remarks | Jasper Therapeutics, Inc. (JSPR) | 13-Jun-23 | Planned Option Sale | 9,000 | $1.66 | $14,914.80 | (3%) 296.22K to 287.22K | |
| 13-Jun-23 10:00 PM View: | Mahal Jeetinder Singh See Remarks | Jasper Therapeutics, Inc. (JSPR) | 13-Jun-23 | Option Exercise | 9,000 | $0.71 | $6,390.00 | 3% 287.22K to 296.22K | |
| 14-Apr-23 4:19 PM View: | French Anna Louise Director | Jasper Therapeutics, Inc. (JSPR) | 14-Apr-23 | Sale | 7,000 | $1.48 | $10,360.00 | (23%) 30.75K to 23.75K | |
| 14-Apr-23 4:14 PM View: | Lis William Director | Jasper Therapeutics, Inc. (JSPR) | 13-Apr-23 | Sale | 8,500 | $1.44 | $12,240.00 | (12%) 69.99K to 61.49K | |
| 14-Apr-23 4:19 PM View: | Emster Kurt von Director | Jasper Therapeutics, Inc. (JSPR) | 13-Apr-23 | Sale | 9,075 | $1.49 | $13,524.50 | (30%) 30.25K to 21.18K | |
| 14-Apr-23 4:16 PM View: | Mahal Jeetinder Singh See Remarks | Jasper Therapeutics, Inc. (JSPR) | 12-Apr-23 | Payment of Exercise | 37,126 | $1.46 | $54,204.00 | (11%) 324.35K to 287.22K | |
| 14-Apr-23 4:17 PM View: | Martell Ron President, CEO and Director Director | Jasper Therapeutics, Inc. (JSPR) | 12-Apr-23 | Payment of Exercise | 87,531 | $1.46 | $127,795.00 | (17%) 506.25K to 418.72K | |
| 11-Apr-23 7:55 PM View: | Qiming U.S. Healthcare Fund... 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 27-Jan-23 | Purchase | 2,666,670 | $1.50 | $4,000,000.00 | 46% 5.85M to 8.52M | |
| 31-Jan-23 5:24 PM View: | Carlyle Group L.P. 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 27-Jan-23 | Purchase | 3,133,330 | $1.50 | $4,700,000.00 | 56% 5.63M to 8.76M | |
| 26-Jan-23 5:49 PM View: | Roche Holding Ltd 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 25-Jan-23 | Sale | 75,000 | $1.89 | $141,750.00 | (2%) 4.62M to 4.55M | |
| 13-Oct-22 8:00 PM View: | Nolet Chris Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 32,500 | -- | -- | 100% 0 to 32.5K | |
| 13-Oct-22 8:02 PM View: | Mahal Jeetinder Singh See Remarks | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 214,722 | -- | -- | 196% 109.63K to 324.35K | |
| 13-Oct-22 8:05 PM View: | Emster Kurt von Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 30,250 | -- | -- | 100% 0 to 30.25K | |
| 13-Oct-22 7:56 PM View: | French Anna Louise Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 30,750 | -- | -- | 100% 0 to 30.75K | |
| 13-Oct-22 8:03 PM View: | Shizuru Judith Anne Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 29,500 | -- | -- | 3% 1.13M to 1.16M | |
| 13-Oct-22 7:58 PM View: | Lis William Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 29,500 | -- | -- | 73% 40.49K to 69.99K | |
| 13-Oct-22 8:07 PM View: | Klein Lawrence Otto Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 24,500 | -- | -- | 100% 0 to 24.5K | |
| 13-Oct-22 8:08 PM View: | Martell Ron President, CEO and Director Director | Jasper Therapeutics, Inc. (JSPR) | 12-Oct-22 | Grant | 506,250 | -- | -- | 100% 0 to 506.25K | |
| 28-Jun-22 4:01 PM View: | Lis William Director | Jasper Therapeutics, Inc. (JSPR) | 27-Jun-22 | Sale (Planned) | 24,743 | $2.08 | $51,403.60 | (38%) 65.23K to 40.49K | |
| 28-Jun-22 4:01 PM View: | Lis William Director | Jasper Therapeutics, Inc. (JSPR) | 24-Jun-22 | Sale (Planned) | 24,743 | $2.02 | $50,030.30 | (28%) 89.97K to 65.23K | |
| 23-Mar-22 6:01 PM View: | Lis William See Remarks Director | Jasper Therapeutics, Inc. (JSPR) | 21-Mar-22 | Grant | 89,972 | -- | -- | 100% 0 to 89.97K | |
| 28-Sep-21 4:32 PM View: | Venkataraman Balaji | Jasper Therapeutics, Inc. (JSPR) | 24-Sep-21 | Option Exercise Duplicate | 2,300,000 | -- | -- | 100% 0 to 2.3M | |
| 28-Sep-21 4:32 PM View: | Hoffen Howard I | Jasper Therapeutics, Inc. (JSPR) | 24-Sep-21 | Option Exercise Duplicate | 2,300,000 | -- | -- | 100% 0 to 2.3M | |
| 28-Sep-21 4:33 PM View: | Clifford Kenneth F | Jasper Therapeutics, Inc. (JSPR) | 24-Sep-21 | Option Exercise Duplicate | 2,300,000 | -- | -- | 100% 0 to 2.3M | |
| 28-Sep-21 4:29 PM View: | Amplitude Healthcare Holdin... 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 24-Sep-21 | Option Exercise | 2,300,000 | -- | -- | 100% 0 to 2.3M | |
| 23-Apr-21 5:15 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 23-Apr-21 | Sale | 151,719 | $9.92 | $1,505,050.00 | (14%) 1.05M to 895.06K | |
| 23-Apr-21 5:15 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 21-Apr-21 | Sale | 1,164 | $9.92 | $11,546.90 | (< 1%) 1.05M to 1.05M | |
| 21-Apr-21 8:09 AM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 19-Apr-21 | Sale | 2,060 | $9.97 | $20,538.20 | (< 1%) 1.05M to 1.05M | |
| 22-Feb-21 6:13 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 22-Feb-21 | Sale | 698 | $10.50 | $7,329.00 | (< 1%) 1.05M to 1.05M | |
| 22-Feb-21 6:13 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 19-Feb-21 | Sale | 2,112 | $10.50 | $22,176.00 | (< 1%) 1.05M to 1.05M | |
| 22-Feb-21 6:13 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 18-Feb-21 | Sale | 10,000 | $10.45 | $104,500.00 | (< 1%) 1.06M to 1.05M | |
| 09-Feb-21 5:45 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 05-Feb-21 | Sale | 212 | $10.40 | $2,204.80 | (< 1%) 1.06M to 1.06M | |
| 19-Jan-21 7:04 PM View: | Glazer Capital, LLC 10% Owner | Jasper Therapeutics, Inc. (JSPR) | 14-Jan-21 | Sale | 101 | $10.40 | $1,050.40 | (< 1%) 1.06M to 1.06M |
